FDA classifies ingestible blood detection capsule as Class II device
/ 1 min read
Table of Contents
The Food and Drug Administration has officially classified a new type of medical device known as an ingestible gastrointestinal blood detection capsule. This device is essentially a pill that uses light absorption technology to detect whether there is blood in the digestive tract.
Why it matters: This action clears a regulatory hurdle for manufacturers, allowing them to bring these diagnostic pills to market more quickly and with less administrative friction. It also sets a precedent, meaning future similar devices can use this classification as a benchmark instead of going through the entire De Novo process again.
Who it affects
- Medical device manufacturers seeking to market ingestible diagnostic capsules
This summary is based on a final order published by the Food and Drug Administration in the Federal Register; readers should consult the original document for full regulatory details.
Agency: Health and Human Services Department, Food and Drug Administration
Source: Federal Register — read the official document